Trametinib for orbital plexiform neurofibromas in young children with neurofibromatosis type 1
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Trametinib for orbital plexiform neurofibromas in young children with neurofibromatosis type 1
Authors
Keywords
-
Journal
CHILDS NERVOUS SYSTEM
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-22
DOI
10.1007/s00381-021-05127-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesions
- (2020) Srivandana Akshintala et al. NEURO-ONCOLOGY
- Selumetinib in Children with Inoperable Plexiform Neurofibromas
- (2020) Andrea M. Gross et al. NEW ENGLAND JOURNAL OF MEDICINE
- An update on the central nervous system manifestations of neurofibromatosis type 1
- (2019) J. Stephen Nix et al. ACTA NEUROPATHOLOGICA
- Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial
- (2019) Jason Fangusaro et al. LANCET ONCOLOGY
- Trametinib Induces Neurofibroma Shrinkage and Enables Surgery
- (2019) Pia Vaassen et al. NEUROPEDIATRICS
- A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01
- (2019) Sébastien Perreault et al. BMC CANCER
- A brief report of plexiform neurofibroma
- (2018) Mahdi Khajavi et al. CURRENT PROBLEMS IN CANCER
- Ophthalmic manifestations in neurofibromatosis type 1
- (2018) Michael Kinori et al. SURVEY OF OPHTHALMOLOGY
- Trametinib in pediatric patients with neurofibromatosis type 1 (NF-1)–associated plexiform neurofibroma: A phase I/IIa study.
- (2018) Geoffrey Brian McCowage et al. JOURNAL OF CLINICAL ONCOLOGY
- Pediatric Brain Tumor Genetics: What Radiologists Need to Know
- (2018) Jehan AlRayahi et al. RADIOGRAPHICS
- A combined one-stage surgical approach of orbital tumor debulking, lid reconstruction, and ptosis repair in children with orbitotemporal neurofibromatosis
- (2017) Shay Keren et al. Journal of Plastic Reconstructive and Aesthetic Surgery
- Orbital/Periorbital Plexiform Neurofibromas in Children with Neurofibromatosis Type 1
- (2017) Robert A. Avery et al. OPHTHALMOLOGY
- Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas
- (2016) Regina I. Jakacki et al. NEURO-ONCOLOGY
- Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas
- (2016) Eva Dombi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cutaneous Reactions in Children Treated with the Mitogen-Activated Protein Kinase Extracellular Signal-Regulated Kinase Inhibitor Trametinib for Neural Tumors
- (2016) Christina Boull et al. PEDIATRIC DERMATOLOGY
- Treatment of neuro-ophthalmic and orbitofacial manifestations of neurofibromatosis type 1
- (2013) Nandini G. Gandhi CURRENT OPINION IN OPHTHALMOLOGY
- Sirolimus for non-progressive NF1-associated plexiform neurofibromas: An NF clinical trials consortium phase II study
- (2013) Brian Weiss et al. PEDIATRIC BLOOD & CANCER
- Orbitofacial neurofibromatosis: clinical characteristics and treatment outcome
- (2011) I A Chaudhry et al. EYE
- Resection of Plexiform Neurofibromas in Children With Neurofibromatosis Type 1
- (2011) Federico Canavese et al. JOURNAL OF PEDIATRIC ORTHOPAEDICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started